B-12Alliance House of Commons Reception
10 September 2026, Terace Pavilion, 2-4pm
Help us drive evidence‑based change that protects lives and improves care.
A Resounding Success at Westminster: Driving Forward Reform for B12 Care
The recent B12 Alliance House of Commons Reception at the Palace of Westminster was an outstanding success, drawing a fantastic turnout of MPs, policymakers, clinicians, researchers, and patients with lived experience.
Through dynamic video displays, informative print media, and research-backed posters, we clearly demonstrated why a standardised national pathway for the clinical diagnosis and treatment of vitamin B12 deficiency is urgently required across the NHS.
Key discussions focused on implementing the recommendations outlined in NICE Guideline NG239—particularly the critical need for improved access to methylmalonic acid (MMA) and other diagnostic testing in primary care. Furthermore, we highlighted how enabling self-administration of sufficiently frequent treatment, alongside easier access to injections for patients with autoimmune conditions like pernicious anaemia, will transform patient outcomes while simultaneously delivering substantial cost savings to the NHS.
The energy and commitment in the room were palpable throughout the afternoon. As one MP aptly remarked, taking these actions is a total "no-brainer" for public health and economic efficiency. We were delighted to secure firm commitments from parliamentary representatives and healthcare leaders to ask crucial questions, pursue follow-ups, and offer ongoing support to help us reach these pivotal goals.
Looking ahead, the momentum is only growing. The House of Commons Reception working group will meet later this month to review the progress made, consolidate our outcomes, and report back to the B-12Alliance on recommendations to drive these reforms forward. Our campaign hasn't finished, so if you can, please donate to support our ongoing work.
Thank you to everyone who attended, supported, and contributed to making this event such a milestone moment for B12 advocacy.
Follow B-12Alliance on LinkedIn or the Charity members on their social media for further updates.
Within CluB-12, the B12-Alliance is the community of patient advocacy groups with relevant expertise and experience. The purpose of the Alliance is to use their shared resources and combined expertise to raise awareness, share evidence-based research and inform the healthcare profession and public about B12 deficiency and about conditions where B12 deficiency is a consequence or risk factor.
Members of the B12 Alliance
B12 Alliance responses to:
NICE guideline [NG239] Published: 06 March 2024
'Vitamin B12 deficiency in over 16s: diagnosis and management'
Research agenda
The B-12 Alliance has identified a series of topics highlighting some of the questions that would need priority from researchers and clinicians for the benefit of people with B12 deficiency. These include a variety of topics related to pathophysiology, diagnostics, and treatment. This list is currently expanding, and we will publish topic descriptions once these become available.